As of September 29, 2026, Edwards Lifesciences's top three insider holders are Michael A Mussallem (Chairman Ceo, 4.04Mn shares), Scott B. Ullem (Cvp, Chief Financial Officer, 266.32K shares), Larry L Wood (Global President Tavr Surg, 206.90K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Larry L Wood | Global President Tavr Surg | 206,900 | 0 | 206,900 | 15.7% | 18 Aug, 2025 |
| 2 | Jean-Luc M Lemercier | Cvp, Emeacla And Japac | 184,686 | 0 | 184,686 | 14.0% | 08 Jul, 2024 |
| 3 | Donald E Jr Bobo | Cvp,Strategy/Corp Development | 0 | 129,581 | 129,581 | 9.8% | 27 May, 2026 |
| 4 | Bernard J Zovighian | Ceo | 98,845 | 8,916 | 107,761 | 8.2% | 27 Jul, 2026 |
| 5 | Theodora Mistras | Cvp, Chief Financial Officer | 99,920 | 0 | 99,920 | 7.6% | 10 Jul, 2026 |
| 6 | Huimin Wang | Cvp, Japan Intercontinental | 99,381 | 0 | 99,381 | 7.5% | 08 Jul, 2022 |
| 7 | Nicholas J Valeriani | Director | 84,423 | 0 | 84,423 | 6.4% | 08 May, 2026 |
| 8 | Catherine M. Szyman | Cvp, Critical Care | 81,287 | 0 | 81,287 | 6.2% | 03 Sep, 2024 |
| 9 | Scott B. Ullem | Cvp, Chief Financial Officer | 46,740 | 0 | 46,740 | 3.5% | 11 May, 2026 |
| 10 | Daveen Chopra | Cvp, Tmtt, Surgical Ihfm | 43,926 | 0 | 43,926 | 3.3% | 11 Sep, 2026 |
| 11 | Daniel J. Lippis | Cvp, Tavr | 40,034 | 0 | 40,034 | 3.0% | 11 Sep, 2026 |
| 12 | Heisz Leslie Stone | Director | 34,199 | 0 | 34,199 | 2.6% | 08 May, 2026 |
| 13 | Martha H. Marsh | Director | 31,880 | 0 | 31,880 | 2.4% | 15 May, 2023 |
| 14 | Wayne Markowitz | Cvp, Japac | 19,371 | 0 | 19,371 | 1.5% | 14 Sep, 2026 |
| 15 | Annette Bruls | Cvp, Emeacla | 17,984 | 0 | 17,984 | 1.4% | 28 Aug, 2026 |
| 16 | Paul A Laviolette | Director | 17,552 | 0 | 17,552 | 1.3% | 08 May, 2026 |
| 17 | Robert W.A. Sellers | Svp, Corporate Controller | 17,081 | 0 | 17,081 | 1.3% | 13 May, 2024 |
| 18 | Andrew M. Dahl | Svp, Corporate Controller | 14,615 | 0 | 14,615 | 1.1% | 14 Sep, 2026 |
| 19 | Leslie C. Davis | Director | 9,834 | 0 | 9,834 | 0.7% | 08 May, 2026 |
| 20 | David T Feinberg | Director | 9,087 | 0 | 9,087 | 0.7% | 08 May, 2026 |
| 21 | Steven R Loranger | Director | 8,997 | 0 | 8,997 | 0.7% | 08 May, 2026 |
| 22 | Ramona Sequeira | Director | 6,779 | 0 | 6,779 | 0.5% | 08 May, 2026 |
| 23 | Michael A Mussallem | Chairman Ceo | 4,486 | 0 | 4,486 | 0.3% | 02 May, 2024 |
| 24 | Kieran Gallahue | Director | 4,315 | 0 | 4,315 | 0.3% | 08 May, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 11 Sep, 2026 | Daniel J. Lippis | Cvp, Tavr | Acquired M | 619 | $72.68 | $44.99K | 40,653 | Direct |
| 11 Sep, 2026 | Daveen Chopra | Cvp, Tmtt, Surgical Ihfm | Disposed F | 398 | $86.77 | $34.53K | 43,926 | Direct |
| 11 Sep, 2026 | Daniel J. Lippis | Cvp, Tavr | Disposed S | 619 | $87.51 | $54.17K | 40,034 | Direct |
| 11 Sep, 2026 | Daniel J. Lippis | Cvp, Tavr | Disposed M | 619 | $0.00 | $0 | 3,714 | Direct |
| 31 Aug, 2026 | Andrew M. Dahl | Svp, Corporate Controller | Disposed S | 544 | $91.06 | $49.53K | 14,868 | Direct |
| 28 Aug, 2026 | Annette Bruls | Cvp, Emeacla | Disposed S | 2,644 | $89.98 | $237.91K | 17,984 | Direct |
| 26 Aug, 2026 | Daveen Chopra | Cvp, Tmtt, Surgical Ihfm | Acquired M | 31,800 | $72.68 | $2.31Mn | 76,124 | Direct |
| 26 Aug, 2026 | Wayne Markowitz | Cvp, Japac | Disposed S | 1,240 | $91.47 | $113.42K | 20,294 | Direct |
| 26 Aug, 2026 | Daveen Chopra | Cvp, Tmtt, Surgical Ihfm | Disposed S | 1,154 | $91.76 | $105.89K | 74,970 | Direct |
| 26 Aug, 2026 | Daveen Chopra | Cvp, Tmtt, Surgical Ihfm | Disposed S | 30,646 | $90.99 | $2.79Mn | 44,324 | Direct |
| 26 Aug, 2026 | Daveen Chopra | Cvp, Tmtt, Surgical Ihfm | Disposed M | 31,800 | $0.00 | $0 | 0 | Direct |
| 11 Aug, 2026 | Daniel J. Lippis | Cvp, Tavr | Acquired M | 619 | $72.68 | $44.99K | 40,653 | Direct |
| 11 Aug, 2026 | Daniel J. Lippis | Cvp, Tavr | Disposed S | 619 | $92.03 | $56.97K | 40,034 | Direct |
| 11 Aug, 2026 | Daniel J. Lippis | Cvp, Tavr | Disposed M | 619 | $0.00 | $0 | 4,333 | Direct |
| 30 Jul, 2026 | Wayne Markowitz | Cvp, Japac | Disposed S | 146 | $86.03 | $12.59K | 21,534 | Direct |
| 28 Jul, 2026 | Wayne Markowitz | Cvp, Japac | Acquired M | 9,628 | $74.02 | $712.66K | 31,308 | Direct |
| 28 Jul, 2026 | Wayne Markowitz | Cvp, Japac | Disposed S | 9,628 | $85.06 | $818.96K | 21,680 | Direct |
| 28 Jul, 2026 | Wayne Markowitz | Cvp, Japac | Disposed M | 9,628 | $0.00 | $0 | 9,628 | Direct |
| 27 Jul, 2026 | Bernard J Zovighian | Ceo | Disposed G | 320 | $0.00 | $0 | 98,845 | Direct |
| 27 Jul, 2026 | Bernard J Zovighian | Ceo | Acquired G | 320 | $0.00 | $0 | 11,836 | Indirect |